Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2020-07-10
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery
NCT02554357
Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study
NCT07146685
Effect of Interscalene Block on Ventilatory Function
NCT01740453
Effective Pain Management During Shoulder Replacement Surgery With EXPAREL
NCT03474510
Ultrasound Guided Local Anesthetic Block: Thoracolumbar Interfascial Plane
NCT02297191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The mechanism of rebound pain is not well known. One of possible mechanism is that the pain stimulus that was blocked suddenly comes out, and it is perceived as more severe pain. The strength of the block may vary depending on the concentration of the local anesthetic. Therefore, the concentration of local anesthetics could affect rebound pain. The aim of this study is evaluation of the effect of local anesthetic concentration on rebound pain after interscalene block for shoulder surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low concentration
Interscalene block with 0.15% ropivacaine 15 ml
Reduced concentration of local anesthetic (ropivacaine)
Reduced concentration of ropivacaine We usually use 0.5% ropivacaine in our facility. The intervention group used 0.15% ropivacaine 15 ml
Usual concentration
Interscalene block with 0.5% ropivacaine 15 ml
Usual concentration of local anesthetic (ropivacaine)
0.5% ropivacaine 15ml
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reduced concentration of local anesthetic (ropivacaine)
Reduced concentration of ropivacaine We usually use 0.5% ropivacaine in our facility. The intervention group used 0.15% ropivacaine 15 ml
Usual concentration of local anesthetic (ropivacaine)
0.5% ropivacaine 15ml
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diabetic neuropathy
* Adverse drug reaction history to ropivacaine, fentanyl
* Impaired coagulation
19 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ajou University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
In-kyong Yi
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
In Kyong Yi, MD
Role: PRINCIPAL_INVESTIGATOR
Ajou University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ajou university school of medicine
Suwon, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yoon Jung Chae, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MED-INT-20-140
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.